Collaborators GF. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105–25. https://doi.org/10.1016/S2468-2667(21)00249-8.

Article  Google Scholar 

Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE, Cummings J. Flier Alzheimer’s disease Lancet. 2021;397(10284):1577–90. https://doi.org/10.1016/S0140-6736(20)32205-4. van der.

Article  CAS  PubMed  Google Scholar 

Heneka MT, Carson MJ, Khoury JE, Landreth GE, Brosseron F, Feinstein DL et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015;14(4):388–405. https://doi.org/10.1016/S1474-4422(15)70016-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gulen MF, Samson N, Keller A, Schwabenland M, Liu C, Gluck S, et al. cGAS-STING drives ageing-related inflammation and neurodegeneration. Nature. 2023;620(7973):374–80. https://doi.org/10.1038/s41586-023-06373-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie X, Ma G, Li X, Zhao J, Zhao Z, Zeng J. Activation of innate immune cGAS-STING pathway contributes to Alzheimer’s pathogenesis in 5xFAD mice. Nat Aging. 2023;3(2):202–12. https://doi.org/10.1038/s43587-022-00337-2.

Article  CAS  PubMed  Google Scholar 

Udeochu JC, Amin S, Huang Y, Fan L, Torres ERS, Carling GK, et al. Gan. Tau activation of microglial cGAS-IFN reduces MEF2C-mediated cognitive resilience. Nat Neurosci. 2023;26(5):737–50. https://doi.org/10.1038/s41593-023-01315-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dai L, Wang Q, Lv X, Gao F, Chen Z, Shen Y. Elevated beta-secretase 1 expression mediates CD4(+) T cell dysfunction via PGE2 signalling in Alzheimer’s disease. Brain Behav Immun. 2021;98:337–48. https://doi.org/10.1016/j.bbi.2021.08.234.

Article  CAS  PubMed  Google Scholar 

Roy ER, Wang B, Wan YW, Chiu G, Cole A, Yin Z, et al. Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J Clin Invest. 2020;130(4):1912–30. https://doi.org/10.1172/jci133737.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Udeochu JC, Amin S, Huang Y, Fan L, Torres ERS, Carling GK, et al. Tau activation of microglial cGAS-IFN reduces MEF2C-mediated cognitive resilience. Nat Neurosci. 2023. https://doi.org/10.1038/s41593-023-01315-6.

Article  PubMed  PubMed Central  Google Scholar 

Roy ER, Chiu G, Li S, Propson NE, Kanchi R, Wang B, Coarfa C, Zheng H. Cao. Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid beta plaques. Immunity. 2022. https://doi.org/10.1016/j.immuni.2022.03.018.

Article  PubMed  PubMed Central  Google Scholar 

Hur JY, Frost GR, Wu X, Crump C, Pan SJ, Wong E, et al. The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer’s disease. Nature. 2020;586(7831):735–40. https://doi.org/10.1038/s41586-020-2681-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR. Stark. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov. 2007;6(12):975–90. https://doi.org/10.1038/nrd2422.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barrat FJ, Crow MK, Ivashkiv LB. Interferon target-gene expression and epigenomic signatures in health and disease. Nat Immunol. 2019;20(12):1574–83. https://doi.org/10.1038/s41590-019-0466-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hubel P, Urban C, Bergant V, Schneider WM, Knauer B, Stukalov A, et al. A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape. Nat Immunol. 2019;20(4):493–502. https://doi.org/10.1038/s41590-019-0323-3.

Article  CAS  PubMed  Google Scholar 

Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol. 2014;32:513–45. https://doi.org/10.1146/annurev-immunol-032713-120231.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lazear HM, Schoggins JW, Diamond MS. Shared and Distinct Functions of Type I and Type III Interferons. Immunity. 2019;50(4):907–23. https://doi.org/10.1016/j.immuni.2019.03.025.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moore Z, Mobilio F, Walker FR, Taylor JM, Crack PJ. Abrogation of type-I interferon signalling alters the microglial response to Aβ(1–42). Sci Rep. 2020;10(1):3153. https://doi.org/10.1038/s41598-020-59917-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Minter MR, Moore Z, Zhang M, Brody KM, Jones NC, Shultz SR, et al. Deletion of the type-1 interferon receptor in APPSWE/PS1∆E9 mice preserves cognitive function and alters glial phenotype. Acta Neuropathol Commun. 2016;4(1):72. https://doi.org/10.1186/s40478-016-0341-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xue F, Tian J, Yu C, Du H, Guo L. Type I interferon response-related microglial Mef2c deregulation at the onset of Alzheimer’s pathology in 5×FAD mice. Neurobiol Dis. 2021;152:105272doi. https://doi.org/10.1016/j.nbd.2021.105272.

Article  CAS  Google Scholar 

Jones RS, Minogue AM, Fitzpatrick O, Lynch MA. Inhibition of JAK2 attenuates the increase in inflammatory markers in microglia from APP/PS1 mice. Neurobiol Aging. 2015;36(10):2716–24. https://doi.org/10.1016/j.neurobiolaging.2015.04.018.

Article  CAS  PubMed  Google Scholar 

Yamamoto M, Kiyota T, Horiba M, Buescher JL, Walsh SM, Gendelman HE, Ikezu T. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. Am J Pathol. 2007;170(2):680–92. https://doi.org/10.2353/ajpath.2007.060378.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taylor JM, Minter MR, Newman AG, Zhang M, Adlard PA, Crack PJ. Type-1 interferon signaling mediates neuro-inflammatory events in models of Alzheimer’s disease. Neurobiol Aging. 2014;35(5):1012–23. https://doi.org/10.1016/j.neurobiolaging.2013.10.089.

Article  CAS  PubMed  Google Scholar 

Minter MR, Main BS, Brody KM, Zhang M, Taylor JM, Crack PJ. Soluble amyloid triggers a myeloid differentiation factor 88 and interferon regulatory factor 7 dependent neuronal type-1 interferon response in vitro. J Neuroinflammation. 2015;12:71. https://doi.org/10.1186/s12974-015-0263-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liao YF, Wang BJ, Cheng HT, Kuo LH, Wolfe MS. Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. J Biol Chem. 2004;279(47):49523–32. https://doi.org/10.1074/jbc.M402034200.

Article  CAS  PubMed  Google Scholar 

Baruch K, Deczkowska A, David E, Castellano JM, Miller O, Kertser A, et al. Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science. 2014;346(6205):89–93. https://doi.org/10.1126/science.1252945.